KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 74 filers reported holding KALA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,704,849 | $9,036,000 | 6.19% |
| RA Capital Management | 10,874,613 | $57,635,000 | 0.92% |
| Mesirow Financial Investment Management, Inc. | 42,104 | $223,000 | 0.57% |
| ACT CAPITAL MANAGEMENT, LLC | 190,000 | $1,007,000 | 0.52% |
| Samsara BioCapital, LLC | 601,162 | $3,186,000 | 0.39% |
| Orbimed Advisors | 5,465,030 | $28,965,000 | 0.29% |
| ALGERT GLOBAL LLC | 72,490 | $384,000 | 0.13% |
| Knights of Columbus Asset Advisors LLC | 236,257 | $1,252,000 | 0.12% |
| Bridgefront Capital, LLC | 47,569 | $252,000 | 0.10% |
| Matisse Capital | 56,100 | $297,000 | 0.09% |